← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 15, 2018Last known activity
Sep 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 9 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (19)
- NCT05993039Overall official - principal investigatorEarly Phase 1Sep 1, 2023
- NCT05993039Reponsible party - principal investigatorEarly Phase 1Sep 1, 2023
- NCT05993039Lead sponsorEarly Phase 1Sep 1, 2023
- NCT05639686Reponsible party - principal investigatorN/ADec 1, 2022
- NCT05639686Lead sponsorN/ADec 1, 2022
- NCT04741204CollaboratorPhase 4Jun 30, 2022
- NCT05177991CollaboratorEarly Phase 1Mar 1, 2022
- NCT05177991Lead sponsorEarly Phase 1Mar 1, 2022
- NCT05177991Sponsor investigatorEarly Phase 1Mar 1, 2022
- NCT05177991Study directorEarly Phase 1Mar 1, 2022
- NCT04794842Reponsible party - principal investigatorEarly Phase 1Aug 1, 2021
- NCT04794842Lead sponsorEarly Phase 1Aug 1, 2021
- NCT04710719Lead sponsorN/AFeb 1, 2021
- NCT04377204Reponsible party - principal investigatorN/AJun 1, 2020
- NCT04377204Lead sponsorN/AJun 1, 2020
Details
- Last known activity
- Sep 1, 2023